BRIEF published on 12/05/2024 at 15:15, 4 months 8 days ago CNS Pharmaceuticals Announces Virtual Analyst & Investor Day CNS Pharmaceuticals Virtual Analyst Day Glioblastoma Multiforme Berubicin TPI 287
BRIEF published on 12/05/2024 at 15:15, 4 months 8 days ago CNS Pharmaceuticals annonce une journée virtuelle pour les analystes et les investisseurs TPI 287 Produits Pharmaceutiques Pour Le Système Nerveux Central Journée Virtuelle Des Analystes Glioblastome Multiforme Bérubicine
PRESS RELEASE published on 12/05/2024 at 15:10, 4 months 8 days ago CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024 CNS Pharmaceuticals, Inc. announces a live webcast discussion with GBM Key Opinion Leaders on Dec 11th. Experts to talk about Berubicin and TPI 287 development Webcast CNS Pharmaceuticals Berubicin TPI 287 GBM
Published on 04/12/2025 at 15:45, 1 day 6 hours ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 20 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 21 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 22 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 2 days ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:38, 2 days 3 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days 3 hours ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 2 days 3 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days 3 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days 4 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days 4 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days 4 hours ago Mise à disposition du Rapport Financier Annuel 2024
